Showing results (101-110 of 117) with videos related to
Sort By:
Pageof 12
The American Journal of Pathology|January 1, 1993
Microinjection of synthetic amyloid beta-protein in monkey cerebral cortex fails to produce acute neurotoxicityM B Podlisny, D T Stephenson, M P Frosch, et al.The American Journal of Forensic Medicine and Pathology|June 1, 1997
Zinc toxicity following massive coin ingestionD R Bennett, C J Baird, K M Chan, et al.Neurobiology of Aging|March 1, 1992
Chronic dietary pergolide preserves nigrostriatal neuronal integrity in aged-Fischer-344 ratsD L Felten, S Y Felten, R W Fuller, et al.Brain Research. Molecular Brain Research|October 23, 1997
Global cerebral ischemia activates nuclear factor-kappa B prior to evidence of DNA fragmentationJ A Clemens, D T Stephenson, E P Dixon, et al.Biochemical and Biophysical Research Communications|March 27, 1996
Nuclear and cytoplasmic localization of the beta-amyloid peptide (1-43) in transfected 293 cellsE M Johnstone, L E Babbey, D Stephenson, et al.Journal of Medicinal Chemistry|May 1, 1980
Bicyclic and tricyclic ergoline partial structures. Rigid 3-(2-aminoethyl)pyrroles and 3- and 4-(2-aminoethyl)pyrazoles as dopamine agonistsN J Bach, E C Kornfeld, N D Jones, et al.The Journal of Biological Chemistry|September 25, 1999
Rat B(2) sequences are induced in the hippocampal CA1 region after transient global cerebral ischemiaX Liu, J A Clemens, T Yin, et al.Stroke|March 1, 1996
Reactive glia express cytosolic phospholipase A2 after transient global forebrain ischemia in the ratJ A Clemens, D T Stephenson, E B Smalstig, et al.The Journal of Pharmacology and Experimental Therapeutics|July 1, 1989
Preclinical studies on quinelorane, a potent and highly selective D2-dopaminergic agonistM M Foreman, R W Fuller, M D Hynes, et al.Drug Design and Discovery|January 1, 1993
Progress in the medicinal chemistry of dopaminergic agentsJ M Schaus, E C Kornfeld, R D Titus, et al.Pageof 12